Insulet (Nasdaq:PODD) today announced new clinical findings for its next-generation Omnipod 6 and fully closed-loop algorithm ...
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced new clinical results ...
Medical Device Network on MSN
Insulet reports new data for Omnipod 6 and FCL systems
Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has shared new ...
Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An updated algorithm for the Omnipod 5 automated insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results